Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

5.48
-0.0700-1.26%
Volume:215.42K
Turnover:1.19M
Market Cap:206.79M
PE:-5.27
High:5.67
Open:5.53
Low:5.40
Close:5.55
52wk High:7.19
52wk Low:1.00
Shares:37.74M
Float Shares:21.41M
Volume Ratio:1.00
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0401
EPS(LYR):-1.1641
ROE:-50.12%
ROA:-30.80%
PB:2.72
PE(LYR):-4.71

Loading ...

AN2 Therapeutics CEO presents at Jefferies Global Healthcare Conference

Reuters
·
May 21

AN2 Therapeutics Inc : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $9.00 From $1.00

THOMSON REUTERS
·
May 14

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Reuters
·
May 14

AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

AN2 Therapeutics Q1 FY26 net loss narrows 5.83% to $10 million

Reuters
·
May 12

AN2 Therapeutics Q1 EPS USD -0.29

THOMSON REUTERS
·
May 12

Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights

Dow Jones
·
May 12

AN2 Therapeutics CEO joins Stifel Virtual Targeted Oncology Forum fireside chat

Reuters
·
May 08

AN2 Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
Apr 30

AN2 Therapeutics announces annual shareholder meeting

Reuters
·
Apr 23

BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies

Reuters
·
Apr 21

AN2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies Llc Dated April 9, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 21

AN2 Therapeutics Inc - May Offer and Sell Common Stock up to $80 Mln Through Jefferies - SEC Filing

THOMSON REUTERS
·
Apr 21

BRIEF-An2 Therapeutics Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing

Reuters
·
Apr 10

AN2 Therapeutics Files $300 Million Mixed Shelf

MT Newswires Live
·
Apr 10

AN2 Therapeutics files $300M mixed securities shelf

TIPRANKS
·
Apr 10

AN2 Therapeutics Inc - May Offer up to $80 Mln of Common Stock Under Agreement With Jefferies Llc - SEC Filing

THOMSON REUTERS
·
Apr 10

AN2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies for up to $80 Mln Common Stock - SEC Filing

THOMSON REUTERS
·
Apr 10

AN2 Therapeutics Inc - Terminates TD Cowen Sales Agreement Effective April 9, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 10

AN2 Therapeutics enters $80 million at-the-market equity sales agreement with Jefferies

Reuters
·
Apr 10